US 12,226,644 B2
Inhibition of onset of cardiac tachyarrhythmia with intercostal nerve stimulation
Stefan G. Kracker, Sonthofen (DE); Lilian Kornet, Eijsden (NL); Michelle M. Galarneau, Eagan, MN (US); Matthew D. Bonner, Plymouth, MN (US); Johan Maas, Winterswijk (NL); Berthold Stegemann, Kassel (DE); Paulus C. van Venrooij, Hoensbroek (NL); Vasiliki Spyropoulou, Bologna (IT); Victor Peter Jozef Duijsens, Grevenbicht (NL); and Markus J. C. Lazeroms, Vroenhoven-Reimst (NL)
Assigned to Medtronic, Inc., Minneapolis, MN (US)
Filed by Medtronic, Inc., Minneapolis, MN (US)
Filed on May 2, 2022, as Appl. No. 17/661,649.
Claims priority of provisional application 63/188,278, filed on May 13, 2021.
Prior Publication US 2022/0362568 A1, Nov. 17, 2022
Int. Cl. A61N 1/39 (2006.01); A61B 5/363 (2021.01)
CPC A61N 1/3987 (2013.01) [A61B 5/363 (2021.01); A61N 1/39622 (2017.08)] 22 Claims
OG exemplary drawing
 
22. A computer-readable storage medium comprising instructions that, when executed by processing circuitry of a medical device comprising a plurality of electrodes, cause the medical device to:
deliver electrical stimulation to an intercostal nerve of a patient via at least two electrodes of the plurality electrodes in response to a heartbeat variability metric satisfying a threshold;
wherein the electrical stimulation is delivered with stimulation parameters configured to suppress ventricular tachyarrhythmia of the patient, wherein the stimulation parameters comprise a stimulation frequency less than or equal to 40 hertz (Hz).